LABCORP HOLDINGS INC. Loss Contingency, Damages Sought, Value
LABCORP HOLDINGS INC. (LH) reported Loss Contingency, Damages Sought, Value of $817.00 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-31.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesSoughtValue · last filed 2026-08-05
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for the quarter ending 2025-03-31 was $817.00M, a 0.00% change year-over-year.
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for the quarter ending 2024-12-31 was -$1.63B.
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for fiscal 2024 was $817.00M, a 0.00% change from fiscal 2023.
- LABCORP HOLDINGS INC. loss contingency, damages sought, value for fiscal 2023 was $817.00M.
| Period end | Loss Contingency, Damages Sought, Value | Loss Contingency, Damages Sought, Value 3 month | Loss Contingency, Damages Sought, Value 6 month | Loss Contingency, Damages Sought, Value 9 month | Loss Contingency, Damages Sought, Value 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $0.00 derived: sum of 2 quarters · filed 2025-10-31 | $817.00M 10-Q · filed 2025-10-31 | -$817.00M derived: sum of 4 quarters · filed 2025-10-31 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $817.00M 10-Q · filed 2025-08-01 | -$817.00M derived: sum of 3 quarters · filed 2025-08-01 | $0.00 derived: sum of 4 quarters · filed 2025-08-01 | |
| 2025-03-31 | $817.00M 10-Q · filed 2025-04-29 | -$817.00M derived: sum of 2 quarters · filed 2025-04-29 | $0.00 derived: sum of 3 quarters · filed 2025-04-29 | $817.00M derived: sum of 4 quarters · filed 2025-04-29 | |
| 2024-12-31 | -$1.63B derived: 10-K 12 month − 3 quarters · filed 2025-02-25 | -$817.00M derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $817.00M 10-K · filed 2025-02-25 | |
| 2024-09-30 | $817.00M 10-Q · filed 2024-10-29 | $1.63B derived: sum of 2 quarters · filed 2024-10-29 | $2.45B derived: sum of 3 quarters · filed 2024-10-29 | $817.00M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2024-06-30 | $817.00M 10-Q · filed 2024-08-02 | $1.63B derived: sum of 2 quarters · filed 2024-08-02 | $0.00 derived: sum of 3 quarters · filed 2024-08-02 | $817.00M derived: sum of 4 quarters · filed 2024-08-02 | |
| 2024-03-31 | $817.00M 10-Q · filed 2024-04-30 | -$817.00M derived: sum of 2 quarters · filed 2024-04-30 | $0.00 derived: sum of 3 quarters · filed 2024-04-30 | $817.00M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2023-12-31 | -$1.63B derived: 10-K 12 month − 3 quarters · filed 2024-02-26 | -$817.00M derived: sum of 2 quarters · filed 2024-02-26 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $817.00M 10-K · filed 2024-02-26 | |
| 2023-09-30 | $817.00M 10-Q · filed 2023-10-30 | $1.63B derived: sum of 2 quarters · filed 2023-10-30 | $2.45B derived: sum of 3 quarters · filed 2023-10-30 | ||
| 2023-06-30 | $817.00M 10-Q · filed 2023-08-04 | $1.63B derived: sum of 2 quarters · filed 2023-08-04 | |||
| 2023-03-31 | $817.00M 10-Q · filed 2023-05-04 | ||||
| 2022-09-22 | $817.00M 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |